(Times of Israel) Shoshanna Solomon - Israeli startup GlucoMe, which has developed a wireless blood glucose monitoring kit to help diabetes patients keep tabs on sugar levels, is collaborating with German pharma giant Merck to try out its kits at five hospitals in Vietnam. According to the International Diabetes Federation, 5.5% of the adult population in Vietnam, or 3.5 million people, suffered from the condition in 2017. Patients will use the monitor to measure their blood sugar levels at home, sync the data through GlucoMe's mobile app, and analyze the data with GlucoMe's Digital Diabetes Clinic and alert system. This will enable medical professionals to identify severe and urgent cases for timely intervention. GlucoMe has also introduced its kits in India and in Central America. Israeli innovation is behind almost half of Merck's healthcare revenues, Kai Beckmann, CEO of Performance Materials at the firm, said in an interview in February.
2018-08-24 00:00:00Full ArticleBACK Visit the Daily Alert Archive